NLRP3-IN-2
NLRP3-IN-2 (5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide), an intermediate capable of synthesizing glibenclamide, exerts an inhibitory effect on the formation of NLRP3 inflammatory vesicles in cardiomyocytes, limiting infarct size after myocardial ischemia/reperfusion in mice and has no effect on metabolism.
| Catalog Number | T3230 |
| Alternative Name(s) | 5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide , NLRP3 Inflammasome Inhibitor I |
| Research Area | NF-Κb|||Immunology/Inflammation |
| Molecular Formula | C16H17ClN2O4S |
| CAS# | 16673-34-0 |
| Purity | 98.98% |
| SMILES | COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C=C1)S(N)(=O)=O |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/NLRP3-IN-2 |
| Additional Information | https://www.targetmol.com/datasheet/T3230 |